◀ Back to IL8

IL8 — RENBP

Text-mined interactions from Literome

Liu et al., FEBS J 2009 : Pharmacological inhibitions of each individual signaling pathway, including p38, extracellular signal regulated kinase 1/2, Jun N-terminal kinase and nuclear factor-kappaB, revealed that activation of all of these four pathways is necessary for the effective induction of interleukin-6, interleukin-8 and monochemoattractant protein-1 by both AGE-HSA and lipopolysaccharide
Rasheed et al., Rheumatology (Oxford) 2011 (Osteoarthritis) : AGE-BSA induced the expression of IL-6 and IL-8 in OA chondrocytes, which was inhibited by pre-treatment with soluble RAGE ( sRAGE ) or RAGE knockdown by siRNAs ... Treatment with SB202190 ( p38-MAPK inhibitor ) or PD98059 ( ERK inhibitor ) inhibited AGE-BSA induced IL-6 and IL-8 expression ... Treatment with NF-?B inhibitors suppressed AGE-BSA induced IL-6 and IL-8 expression ... These results demonstrate that AGE-BSA induced expression of IL-6 and IL-8 via RAGE is mediated through different MAPK signalling pathways in OA and possibly in other degenerative diseases
Cheng et al., International journal of biological sciences 2013 : TLR4 siRNA showed stronger inhibition on AGE-LDL induced IL-6 and IL-8 production than that of TLR2 siRNA ... Silencing MyD88, but not TRIF, inhibited AGE-LDL induced IL-6 and IL-8 production ... Conclusion : AGE-LDL induced IL-6 and IL-8 production via TLR2/4-MyD88 dependent pathway in tubular epithelial cells